Tilray Brands (TLRY) Price/FCF Ratio: History & Chart

Tilray Brands, Inc.(TLRY)

Drug Manufacturers - Specialty & Generic · Leamington, ON

$3.79+0.06 (+1.75%)

Delayed quote: Oct 6, 2026, 3:50 PM EDT

About Tilray Brands, Inc.

Tilray Brands, Inc. is a diversified global consumer packaged goods company primarily involved in the cultivation, processing, marketing, and sale of cannabis products. Its operations span a significant international footprint, encompassing Canada, the United States, Europe, Australia, New Zealand, and Latin America. The company organizes its business across four distinct divisions: Cannabis, Distribution, Beverage Alcohol, and Wellness. Within its cannabis division, Tilray provides a comprehensive range of medical and adult-use items, including regulated products like GMP-certified cannabis flowers, oils, vaporizers, edibles, and topical applications. Beyond cannabis, Tilray's portfolio extends to the procurement and resale of pharmaceutical and wellness goods. Furthermore, it manufactures, promotes, and distributes a variety of alcoholic beverages, alongside hemp-derived food and other wellness items. The company markets its diverse offerings under numerous recognized brands, such as Tilray, Aphria, SweetWater, and Breckenridge Distillery. Its products reach a wide array of customers, including retail outlets, wholesale partners, medical patients, healthcare practitioners, hospitals, pharmacies, scientific researchers, governmental bodies, and directly to end consumers. Formerly operating as Tilray, Inc., the corporation is headquartered in Leamington, Canada.

Leamington, ON

3,595 employees

www.tilray.com

Healthcare / Drug Manufacturers - Specialty & Generic

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
CEO: Irwin David Simon

View full financials

NAME	MARKET CAP	PRICE/FCF RATIO	TTM	3Y	5Y
Tilray Brands, Inc. (TLRY)	$423.28M	N/A	N/A	N/A	N/A
Tectonic Therapeutic, Inc. (TECX)vs ›	$423.00M	N/A	N/A	N/A	N/A
ARS Pharmaceuticals, Inc. (SPRY)vs ›	$422.54M	N/A	102.37	102.37	102.37
Editas Medicine, Inc. (EDIT)vs ›	$417.71M	N/A	53.84	53.84	53.84
Prothena Corporation plc (PRTA)vs ›	$419.61M	N/A	44.26	44.26	44.26
NeoGenomics, Inc. (NEO)vs ›	$425.64M	N/A	53.25	37.33	28.89
Senseonics Holdings, Inc. (SENS)vs ›	$417.56M	N/A	N/A	N/A	N/A
MapLight Therapeutics, Inc. (MPLT)vs ›	$412.91M	N/A	N/A	N/A	N/A
Strata Critical Medical, Inc. (SRTA)vs ›	$411.43M	N/A	198.72	198.72	198.72
NeuroPace, Inc. (NPCE)vs ›	$435.38M	N/A	N/A	N/A	N/A

NAME

MARKET CAP

PRICE/FCF RATIO

TTM

Tilray Brands, Inc. (TLRY)

$423.28M

N/A

Tectonic Therapeutic, Inc. (TECX)vs ›

$423.00M

N/A

ARS Pharmaceuticals, Inc. (SPRY)vs ›

$422.54M